miRNA-205: a future therapeutic molecule for liver diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miRNA-205: a future therapeutic molecule for liver diseases

Published:2022-09 Issue:3 Volume:4 Page:
ISSN:2631-3316
Container-title:Future Drug Discovery
language:en
Short-container-title:Future Drug Discovery

Author:

Cabrera Marco¹²,Kolli Meghana¹²,Jaggi Meena¹²,Chauhan Subhash C¹²,Yallapu Murali M¹²

Affiliation:

1. Department of Immunology & Microbiology, School of Medicine, The University of Texas Rio Grande Valley, McAllen, TX 78504, USA

2. South Texas Center of Excellence in Cancer Research, School of Medicine, The University of Texas Rio Grande Valley, McAllen, TX 78504, USA

Funder

National Institutes of Health

Publisher

Future Science Ltd

Subject

General Medicine

Link

https://www.future-science.com/doi/pdf/10.4155/fdd-2022-0012

Reference30 articles.

1. Burden of liver diseases in the world

2. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

3. Overexpression of Micro Ribonucleic Acid 29, Highly Up-Regulated in Diabetic Rats, Leads to Insulin Resistance in 3T3-L1 Adipocytes

4. CHANGES IN microRNA (miR) PROFILE AND EFFECTS OF miR-320 IN INSULIN-RESISTANT 3T3-L1 ADIPOCYTES

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating miRNA-192 and miR-29a as Disease Progression Biomarkers in Hepatitis C Patients with a Prevalence of HCV Genotype 3;Genes;2023-05-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP